NCT07512856 The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
| NCT ID | NCT07512856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-02-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Eligibility Criteria
Inclusion Criteria: * Self-identified transgender women, transgender men, or non-binary persons * Age ≥18 years * HIV-negative * Engaged in chemsex or substance use within past 12 months * Able to provide informed consent Exclusion Criteria: • Inability to communicate in Thai sufficiently to complete study procedures
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.